Leyla Shune MD, discusses Safety analysis of axatilimab in patients with chronic graft-versus-host disease in an expanded access program.
Leyla Shune, MD
Advertisement
Articles by Leyla Shune, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
The Role of Elacestrant in ER+/HER2– Advanced Breast Cancer Harboring ESR1 Mutations
2
Nemtabrutinib With Venetoclax Shows Promising Activity in R/R CLL/SLL
3
Maintenance Gemogenovatucel-T Shows Survival Benefit in cTMB-High/HRP Ovarian Cancer
4
Pembrolizumab Fails to Yield Responses in Recurrent Medullary Thyroid Cancer
5